Prostate Artery Embolization via Distal Transradial Artery Access in a 100-Year-Old Patient

Author:

Yeh Shauh-Der12,Weng Yu-Shiou3,Lin Chun-Yu4

Affiliation:

1. Department of Urology, Prostate Center of Excellence and Cancer Center, Taipei Medical University Hospital, Taipei 11031, Taiwan

2. Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan

3. Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan

4. Department of Radiology, Yonghe Cardinal Tien Hospital, New Taipei City 23445, Taiwan

Abstract

Benign prostatic obstruction (BPH) is a common disease in males and surgical treatment is the gold standard for this symptomatic disease. Prostate artery embolization (PAE) is one of the emerging therapies which aims to minimize the lower urinary tract symptoms (LUTS) of BPH and the volume of enlarged prostates. We reported here a case of 100-year-old man with 90 cm3 prostate and severe symptoms secondary to BPH, who underwent a successful PAE through distal transradial access without any complications. The patient was satisfied with this treatment and no symptoms recurred after PAE. This demonstrated that PAE was a safe and effective treatment for BPH and was recommended for elderly/non-surgical candidates.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference16 articles.

1. The development of human benign prostatic hyperplasia with age;Berry;J. Urol.,1984

2. HoLEP: The new gold standard for surgical treatment of benign prostatic hyperplasia;Shvero;Can. J. Urol.,2021

3. Prostate Artery Embolization via Transradial or Transulnar versus Transfemoral Arterial Access: Technical Results;Bhatia;J. Vasc. Interv. Radiol.,2017

4. Ontario Health (Quality) (2021). Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment. Ont. Health Technol. Assess. Ser., 21, 1–139.

5. Transradial Access for Interventional Radiology: Single-Centre Procedural and Clinical Outcome Analysis;Thakor;Can. Assoc. Radiol. J.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3